Skip to main content

Michel Goldman

Michel Goldman

4 commentaries

Michel Goldman, President of the Institute for Interdisciplinary Innovation in Healthcare (I3h) and Emeritus Professor of Immunology at the Université Libre de Bruxelles, was executive director of the Innovative Medicines Initiative from 2009 to 2014.

Sort by: Show:
  5. op_galbraith7_claffraGetty Images_USdollareconomy
    Subscriber Exclusive

    Dismal Economics

    James K. Galbraith

    Although neoclassical economics relies on assumptions that should have been discarded long ago, it remains the mainstream orthodoxy. Three recent books, and one older one, help to show why its staying power should be regarded as a scandal.

     reviews four books that shed light on the unjustifiable hegemony of the neoclassical school.
    3

Edit Newsletter Preferences

Set up Notification

To receive email updates regarding this {entity_type}, please enter your email below.

If you are not already registered, this will create a PS account for you. You should receive an activation email shortly.